N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-mercaptopropanami | 1370037-52-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-mercaptopropanami
• 英文别名: N-[6-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl]-3-sulfanylpropanamide
• CAS: 1370037-52-7
• 化学式: C₂₂H₃₀ClN₃OS
• 分子量: 420.019
• InChiKey: KNYZLSNPSSAHIF-UHFFFAOYSA-N

物化性质

• 沸点：
  673.2±55.0 °C(Predicted)
• 密度：
  1.210±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  28
• 可旋转键数：
  10
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  55
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  N¹-(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)hexane-1,6-diamine 在 盐酸 、 水 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 24.5h， 生成 N-(6-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino)hexyl)-3-mercaptopropanami
  参考文献：
  名称：

  Multifunctional Mercapto-tacrine Derivatives for Treatment of Age-Related Neurodegenerative Diseases

  摘要：

  Cooperating mercapto groups with tacrine in a single molecular, novel multifunctional compounds have been designed and synthesized. These mercapto-tacrine derivatives displayed a synergistic pharmacological profile of long-term potentiation enhancement, cholinesterase inhibition, neuroprotection, and less hepatotoxicity, emerging as promising molecules for the therapy of age-related neurodegenerative diseases.

  DOI：

  10.1021/jm300124p

文献信息

• Multifunctional Mercapto-tacrine Derivatives for Treatment of Age-Related Neurodegenerative Diseases
  作者：Yue Wang、Xin-Lei Guan、Peng-Fei Wu、Can-Ming Wang、Hui Cao、Lei Li、Xiao-Juan Guo、Fang Wang、Na Xie、Feng-Chao Jiang、Jian-Guo Chen

  DOI：10.1021/jm300124p

  日期：2012.4.12

  Cooperating mercapto groups with tacrine in a single molecular, novel multifunctional compounds have been designed and synthesized. These mercapto-tacrine derivatives displayed a synergistic pharmacological profile of long-term potentiation enhancement, cholinesterase inhibition, neuroprotection, and less hepatotoxicity, emerging as promising molecules for the therapy of age-related neurodegenerative diseases.